
### [MONDO:0005138](http://purl.obolibrary.org/obo/MONDO_0005138)
**Label:** lung carcinoma

**Subclasses:** [MONDO:0016644](http://purl.obolibrary.org/obo/MONDO_0016644) (Logopenic progressive aphasia), [MONDO:0003128](http://purl.obolibrary.org/obo/MONDO_0003128) (classic pulmonary blastoma), [MONDO:0000531](http://purl.obolibrary.org/obo/MONDO_0000531) (bronchus mucoepidermoid carcinoma), [MONDO:0000894](http://purl.obolibrary.org/obo/MONDO_0000894) (mucinous bronchioloalveolar adenocarcinoma), [MONDO:0000895](http://purl.obolibrary.org/obo/MONDO_0000895) (nonmucinous bronchioloalveolar adenocarcinoma), [MONDO:0000532](http://purl.obolibrary.org/obo/MONDO_0000532) (lung combined type small cell adenocarcinoma), [MONDO:0017292](http://purl.obolibrary.org/obo/MONDO_0017292) (well-differentiated fetal adenocarcinoma of the lung), [MONDO:0003129](http://purl.obolibrary.org/obo/MONDO_0003129) (epithelial predominant pulmonary blastoma), [MONDO:0004973](http://purl.obolibrary.org/obo/MONDO_0004973) (adenosquamous lung carcinoma), [MONDO:0000375](http://purl.obolibrary.org/obo/MONDO_0000375) (bronchus carcinoma in situ), [MONDO:0003960](http://purl.obolibrary.org/obo/MONDO_0003960) (pulmonary large cell neuroendocrine carcinoma), [MONDO:0004499](http://purl.obolibrary.org/obo/MONDO_0004499) (hilar lung carcinoma), [MONDO:0000893](http://purl.obolibrary.org/obo/MONDO_0000893) (mixed mucinous and nonmucinous bronchioloalveolar adenocarcinoma), [MONDO:0006279](http://purl.obolibrary.org/obo/MONDO_0006279) (lung sarcomatoid carcinoma), [MONDO:0006277](http://purl.obolibrary.org/obo/MONDO_0006277) (lung lymphangioleiomyomatosis), [MONDO:0006276](http://purl.obolibrary.org/obo/MONDO_0006276) (lung inflammatory myofibroblastic tumor), [MONDO:0006275](http://purl.obolibrary.org/obo/MONDO_0006275) (lung giant cell carcinoma), [MONDO:0004295](http://purl.obolibrary.org/obo/MONDO_0004295) (asbestos-related lung carcinoma), [MONDO:0005061](http://purl.obolibrary.org/obo/MONDO_0005061) (lung adenocarcinoma), [MONDO:0002806](http://purl.obolibrary.org/obo/MONDO_0002806) (bronchus carcinoma), [MONDO:0017288](http://purl.obolibrary.org/obo/MONDO_0017288) (dicer1 syndrome), [MONDO:0017289](http://purl.obolibrary.org/obo/MONDO_0017289) (fetal lung interstitial tumor), [MONDO:0000503](http://purl.obolibrary.org/obo/MONDO_0000503) (in situ pulmonary adenocarcinoma), [MONDO:0004500](http://purl.obolibrary.org/obo/MONDO_0004500) (lung superior sulcus carcinoma), [MONDO:0006049](http://purl.obolibrary.org/obo/MONDO_0006049) (papillary lung adenocarcinoma), [MONDO:0005233](http://purl.obolibrary.org/obo/MONDO_0005233) (non-small cell lung carcinoma (disease)), [MONDO:0006883](http://purl.obolibrary.org/obo/MONDO_0006883) (Pancoast tumor), [MONDO:0003892](http://purl.obolibrary.org/obo/MONDO_0003892) (acinar lung adenocarcinoma), [MONDO:0004142](http://purl.obolibrary.org/obo/MONDO_0004142) (lung combined large cell neuroendocrine carcinoma), [MONDO:0006167](http://purl.obolibrary.org/obo/MONDO_0006167) (combined lung carcinoma), [MONDO:0004660](http://purl.obolibrary.org/obo/MONDO_0004660) (lung carcinoma in situ), [MONDO:0003050](http://purl.obolibrary.org/obo/MONDO_0003050) (lung large cell carcinoma), [MONDO:0006281](http://purl.obolibrary.org/obo/MONDO_0006281) (lung signet ring cell carcinoma), [MONDO:0006280](http://purl.obolibrary.org/obo/MONDO_0006280) (lung sclerosing hemangioma), [MONDO:0003904](http://purl.obolibrary.org/obo/MONDO_0003904) (lung occult squamous cell carcinoma), [MONDO:0004237](http://purl.obolibrary.org/obo/MONDO_0004237) (large cell carcinoma with rhabdoid phenotype), [MONDO:0004991](http://purl.obolibrary.org/obo/MONDO_0004991) (bronchoalveolar adenocarcinoma), [MONDO:0003181](http://purl.obolibrary.org/obo/MONDO_0003181) (lung adenoid cystic carcinoma), [MONDO:0011014](http://purl.obolibrary.org/obo/MONDO_0011014) (pleuropulmonary blastoma), [MONDO:0008433](http://purl.obolibrary.org/obo/MONDO_0008433) (small cell lung carcinoma), [MONDO:0020555](http://purl.obolibrary.org/obo/MONDO_0020555) (pleuropulmonary blastoma type 1), [MONDO:0003437](http://purl.obolibrary.org/obo/MONDO_0003437) (occult small cell lung carcinoma), [MONDO:0005616](http://purl.obolibrary.org/obo/MONDO_0005616) (pulmonary mucoepidermoid carcinoma), [MONDO:0003438](http://purl.obolibrary.org/obo/MONDO_0003438) (combined small cell lung carcinoma), [MONDO:0020556](http://purl.obolibrary.org/obo/MONDO_0020556) (pleuropulmonary blastoma type 2), [MONDO:0020557](http://purl.obolibrary.org/obo/MONDO_0020557) (pleuropulmonary blastoma type 3), [MONDO:0005933](http://purl.obolibrary.org/obo/MONDO_0005933) (pulmonary blastoma), [MONDO:0004128](http://purl.obolibrary.org/obo/MONDO_0004128) (lung occult large cell carcinoma), [MONDO:0003436](http://purl.obolibrary.org/obo/MONDO_0003436) (lung oat cell carcinoma), [MONDO:0004127](http://purl.obolibrary.org/obo/MONDO_0004127) (lung occult adenocarcinoma), [MONDO:0004087](http://purl.obolibrary.org/obo/MONDO_0004087) (basaloid lung carcinoma), [MONDO:0006024](http://purl.obolibrary.org/obo/MONDO_0006024) (anaplastic lung carcinoma), [MONDO:0005097](http://purl.obolibrary.org/obo/MONDO_0005097) (squamous cell lung carcinoma), 

**Mapped go classes:** [GO:0035068](http://purl.obolibrary.org/obo/GO_0035068) (micro-ribonucleoprotein complex), [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0004386](http://purl.obolibrary.org/obo/GO_0004386) (helicase activity), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0004519](http://purl.obolibrary.org/obo/GO_0004519) (endonuclease activity), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0016891](http://purl.obolibrary.org/obo/GO_0016891) (endoribonuclease activity, producing 5'-phosphomonoesters), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0070883](http://purl.obolibrary.org/obo/GO_0070883) (pre-miRNA binding), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0030422](http://purl.obolibrary.org/obo/GO_0030422) (production of siRNA involved in RNA interference), [GO:0035279](http://purl.obolibrary.org/obo/GO_0035279) (mRNA cleavage involved in gene silencing by miRNA), [GO:0030423](http://purl.obolibrary.org/obo/GO_0030423) (targeting of mRNA for destruction involved in RNA interference), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0031054](http://purl.obolibrary.org/obo/GO_0031054) (pre-miRNA processing), [GO:0035195](http://purl.obolibrary.org/obo/GO_0035195) (gene silencing by miRNA), [GO:0035196](http://purl.obolibrary.org/obo/GO_0035196) (production of miRNAs involved in gene silencing by miRNA), [GO:0006396](http://purl.obolibrary.org/obo/GO_0006396) (RNA processing), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0004530](http://purl.obolibrary.org/obo/GO_0004530) (deoxyribonuclease I activity), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0004525](http://purl.obolibrary.org/obo/GO_0004525) (ribonuclease III activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0006309](http://purl.obolibrary.org/obo/GO_0006309) (apoptotic DNA fragmentation), [GO:0031047](http://purl.obolibrary.org/obo/GO_0031047) (gene silencing by RNA), [GO:0070578](http://purl.obolibrary.org/obo/GO_0070578) (RISC-loading complex), [GO:0016442](http://purl.obolibrary.org/obo/GO_0016442) (RISC complex), [GO:0050767](http://purl.obolibrary.org/obo/GO_0050767) (regulation of neurogenesis), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0098795](http://purl.obolibrary.org/obo/GO_0098795) (mRNA cleavage involved in gene silencing) 53.33%
- [GO:0070918](http://purl.obolibrary.org/obo/GO_0070918) (production of small RNA involved in gene silencing by RNA) 53.33%
- [GO:0070578](http://purl.obolibrary.org/obo/GO_0070578) (RISC-loading complex) 53.33%
- [GO:0035279](http://purl.obolibrary.org/obo/GO_0035279) (mRNA cleavage involved in gene silencing by miRNA) 53.33%
- [GO:0035196](http://purl.obolibrary.org/obo/GO_0035196) (production of miRNAs involved in gene silencing by miRNA) 53.33%
- [GO:0035195](http://purl.obolibrary.org/obo/GO_0035195) (gene silencing by miRNA) 53.33%
- [GO:0035194](http://purl.obolibrary.org/obo/GO_0035194) (posttranscriptional gene silencing by RNA) 53.33%
- [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex) 53.33%
- [GO:0035068](http://purl.obolibrary.org/obo/GO_0035068) (micro-ribonucleoprotein complex) 53.33%
- [GO:0031332](http://purl.obolibrary.org/obo/GO_0031332) (RNAi effector complex) 53.33%
- [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance) 53.33%
- [GO:0031054](http://purl.obolibrary.org/obo/GO_0031054) (pre-miRNA processing) 53.33%
- [GO:0031050](http://purl.obolibrary.org/obo/GO_0031050) (dsRNA fragmentation) 53.33%
- [GO:0031047](http://purl.obolibrary.org/obo/GO_0031047) (gene silencing by RNA) 53.33%
- [GO:0030423](http://purl.obolibrary.org/obo/GO_0030423) (targeting of mRNA for destruction involved in RNA interference) 53.33%


